EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β ‐cells

Guillaume Gautheron, Sylvie Péraldi-Roux, Justine Vaillé, Sahla Belhadj, Andrzej Patyra iD, Morgane Bayle, Estelle Youl, Soufiyan Omhmmed, Mélanie Guyot, Gérard Cros, Jean-Francois Guichou, Benjamin Uzan und 4 weitere

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Guillaume Gautheron und 15 weiteren Autor:innen. Beteiligte Einrichtung: IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Insulin Secretion, Insulin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose The pharmacology of flavonoids on β ‐cell function is largely undefined especially in the context of defective secretion of insulin. We sought to identify flavonoids that increased the insulin‐secreting function of β ‐cells and to explore the underlying mechanisms. Experimental Approach INS‐1 β ‐cells in culture and islets of Langerhans isolated from control and diabetic male rats were used for insulin secretion experiments. Pharmacological and electrophysiological approaches were used for mechanistic studies. Key Results Among a set of flavonoids, exposure of INS‐1 β ‐cells to resokaempferol (ResoK) enhanced glucose‐stimulated insulin secretion and therefore we further characterised its activity and its pharmacological mechanism. ResoK glucose‐dependently enhanced insulin secretion in INS‐1 β ‐cells and pancreatic islets isolated from rats. Mechanistically, whole cell patch clamp recordings in INS‐1 cells showed that ResoK rapidly and dose‐dependently enhanced the L‐type Ca 2+ current whereas it was inactive towards T‐type Ca 2+ current. Accordingly, pharmacological inhibition of L‐type Ca 2+ current but not T‐type Ca 2+ current blocked the effects of ResoK on glucose‐stimulated insulin secretion. ResoK was still active on dysfunctional β ‐cells as it ameliorated glucose‐stimulated insulin secretion in glucotoxicity‐induced dysfunctional INS‐1 cells and in pancreatic islets isolated from diabetic rats. Conclusion and Implications ResoK is a glucose‐dependent activator of insulin secretion. Our results indicated that the effects of ResoK on insulin secretion involved its capacity to stimulate L‐type Ca 2+ currents in cultured β ‐cells. As ResoK was also effective on dysfunctional β ‐cells, our work provides a new approach to stimulating insulin secretion, using compounds based on the structure of ResoK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsInsulin SecretionInsulinAnimalsMaleRatsGlucoseDiabetes Mellitus, ExperimentalFlavonoidsRats, WistarDose-Response Relationship, DrugCells, CulturedRats, Sprague-DawleyFlavones

Stichwörter der Autor:innen

calcium channeldiabetesinsulin secretionnatural productspolyphenol

Substanzen

InsulinGlucoseFlavonoidsFlavones

Autor:innen und Institutionen

  • IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
  • Department of Pharmaceutical Biology, Medical University of Warsaw, Warsaw, Poland.
  • CBS, Univ Montpellier, CNRS, INSERM, Montpellier, France.
  • Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.
  • Centre de Recherche Cardio-Thoracique de Bordeaux, Univ. Bordeaux, Pessac, France.
  • INSERM, Centre de Recherche Cardio-Thoracique de Bordeaux, Pessac, France.

ORCID-Profile: Andrzej Patyra, Jamileh Movassat, Jérémie Neasta, Catherine Oiry

Zitieren

APA

Gautheron, G., Péraldi-Roux, S., Vaillé, J., Belhadj, S., Patyra, A., Bayle, M., Youl, E., Omhmmed, S., Guyot, M., Cros, G., Guichou, J. F., Uzan, B., Movassat, J., Quignard, J. F., Neasta, J., & Oiry, C. (2025). The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β ‐cells. British Journal of Pharmacology. https://doi.org/10.1111/bph.17304

Vancouver

Gautheron G, Péraldi-Roux S, Vaillé J, Belhadj S, Patyra A, Bayle M, et al. The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β ‐cells. British Journal of Pharmacology. 2025. doi:10.1111/bph.17304

BibTeX
@article{Gautheron2025,
  author = {Gautheron, Guillaume and Péraldi-Roux, Sylvie and Vaillé, Justine and Belhadj, Sahla and Patyra, Andrzej and Bayle, Morgane and Youl, Estelle and Omhmmed, Soufiyan and Guyot, Mélanie and Cros, Gérard and Guichou, Jean-Francois and Uzan, Benjamin and Movassat, Jamileh and Quignard, Jean-François and Neasta, Jérémie and Oiry, Catherine},
  title = {The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β ‐cells},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17304}
}
Kostenlos starten →